Effect of acupuncture added to standard treatment of migraine.

Effect of acupuncture added to standard treatment of migraine. - ACU -MIG - 001

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00009803

Enrollment

Registered

2015-12-23

Start date

2015-10-20

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G43.9

Interventions

Group 1: Group of patients treated with acupuncture added to standard pharmacological treatment of migraine. During the 12-week treatment period acupuncture will be given 14 times. Localization of a

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients (men and women) in the age interval 18-80 years old with a history of migraines at least 12 months with a minimum rate of 4 attacks / days per month.

Exclusion criteria

Exclusion criteria: Malignant disease, pregnant women, patients with a history of acupuncture in the face, hands, feet and the front of the body in the previous 6 months, with a history of head injury or cringe spine, severe arrhythmias, heart failure, brain tumor, epilepsy, haemophilia patients participating other clinical trials within the previous 6 months, patients unable to distinguish between tension headache and migraine patients receiving anticoagulant therapy, patients taking Chinese herbs (Chinese herbal medicine).

Design outcomes

Primary

Measure	Time frame
The primary objective of monitoring is to determine the frequency, duration and intensity of migraines. The intensity of migraine will be determined by visual analogue scale (Visual Analogue Scale, VAS hereinafter). Pain intensity ratings will be subject recorded in his diary during the whole project. At the same time we determined the percentage of patients with more than 50% reduction in the attack / migraine days for 4 weeks. Duration of the project is 36 weeks: 12 weeks treatment period + 24 weeks patient follow-up.	—

Measure

Time frame

The primary objective of monitoring is to determine the frequency, duration and intensity of migraines. The intensity of migraine will be determined by visual analogue scale (Visual Analogue Scale, VAS hereinafter). Pain intensity ratings will be subject recorded in his diary during the whole project. At the same time we determined the percentage of patients with more than 50% reduction in the attack / migraine days for 4 weeks. Duration of the project is 36 weeks: 12 weeks treatment period + 24 weeks patient follow-up.

—

Secondary

Measure	Time frame
The secondary objective is monitoring the drop in intake migraine medications, evaluating the severity and course of migraine and quality of life, including psychosocial factors. To evaluate the quality of life questionnaire will be used MIDAS (Migraine Disability Assessment) questionnaire (visits W4, W8, W12, W24, W36). WHO Life satisfaction questionnaire is used for measuring the quality of life and life satisfaction.	—

Measure

Time frame

The secondary objective is monitoring the drop in intake migraine medications, evaluating the severity and course of migraine and quality of life, including psychosocial factors. To evaluate the quality of life questionnaire will be used MIDAS (Migraine Disability Assessment) questionnaire (visits W4, W8, W12, W24, W36). WHO Life satisfaction questionnaire is used for measuring the quality of life and life satisfaction.

—

Countries

Czechia

Contacts

Public ContactJitka Pokladnikova

Dpt. of Social and Clinical Pharmacy, Faculty of Pharmacy, Charles University Hradec Kralove

poklj7aa@faf.cuni.cz+420495067321

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 5, 2026